Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
  • Price (USD)70.25
  • Today's Change-0.73 / -1.03%
  • Shares traded441.32k
  • 1 Year change-7.16%
  • Beta1.3242
Data delayed at least 15 minutes, as of Apr 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 10 CTC locations in North Carolina and 160 locations in 32 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates a network of over 253 behavioral healthcare facilities with 11,200 beds in 38 states and Puerto Rico.

  • Revenue in USD (TTM)2.93bn
  • Net income in USD-21.67m
  • Incorporated2005
  • Employees17.00k
  • Location
    Acadia Healthcare Company IncSUITE 610, 830 CRESCENT CENTRE DRIVEFRANKLIN 37067United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ACHC:NSQ since
announced
Transaction
value
Undisclosed Comprehensive Treatment Center,North Carolina(3)Deal completed28 Mar 202428 Mar 2024Deal completed-10.33%--
Data delayed at least 15 minutes, as of Apr 17 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Irhythm Technologies Inc492.68m-123.41m3.40bn2.00k--16.18--6.91-4.04-4.0416.146.791.1211.058.85246,340.50-28.00-21.92-36.04-26.7767.3569.39-25.05-25.752.02-26.910.1426--19.9027.32-6.24--50.82--
Evolent Health Inc1.96bn-142.26m3.48bn4.70k--3.22--1.77-1.28-1.2817.6510.940.8733--5.60417,850.20-5.03-9.60-6.67-12.5923.4524.50-5.76-13.66--0.26850.3239--45.2625.65-660.71---6.18--
Select Medical Holdings Corp6.66bn234.72m3.50bn38.40k14.452.726.890.52571.891.8953.7610.040.868--7.08173,543.203.904.194.845.4613.9913.984.505.11--3.520.700915.305.225.5753.0311.986.50--
Radnet Inc1.62bn3.04m3.51bn7.87k53,211.115.1622.082.170.00090.000925.329.280.631--8.64205,364.601.181.241.561.6621.6721.561.881.86--1.470.50510.0013.0510.64-71.42-37.6319.60--
PACS Group Inc-100.00bn-100.00bn3.63bn32.43k------------------------------------------------28.47---25.00------
CorVel Corp773.52m74.97m4.03bn4.44k54.5717.2439.945.204.324.3244.5313.661.81--8.82174,059.6017.5814.2931.3822.8922.0122.059.698.78----0.000.0011.195.17-0.067815.28-1.01--
Option Care Health Inc4.30bn267.09m5.44bn5.81k21.173.8516.531.271.481.4823.838.141.3613.3311.39740,630.808.443.6310.384.3522.8122.456.212.781.336.880.42770.009.0643.4277.40--24.72--
Acadia Healthcare Company Inc2.93bn-21.67m6.56bn17.00k--2.3356.222.24-0.2432-0.243232.0730.480.5661--8.56172,278.70-0.30272.32-0.35282.64-----0.53475.600.66696.170.3222--12.208.99-107.93--3.34--
Ensign Group Inc3.73bn209.40m6.70bn35.30k32.184.4623.721.803.663.6665.0726.360.9776--8.35105,647.505.506.456.667.8821.6822.325.636.48--39.170.09086.5623.2716.28-6.8028.624.405.02
Encompass Health Corp4.80bn361.60m8.01bn22.36k22.414.8710.691.673.573.4547.3816.430.818--8.36214,761.108.096.3710.217.9495.4595.589.899.16--5.290.541530.7810.412.3441.314.4916.60-10.42
Chemed Corp2.26bn272.51m9.23bn15.09k34.048.2827.704.0817.9217.92148.9973.691.46131.5914.11150,090.6017.5219.5321.7924.6435.2834.6012.0312.601.57--0.0148.156.064.909.175.801.466.10
Tenet Healthcare Corp20.55bn611.00m9.83bn78.14k16.856.114.510.47825.835.83196.0016.090.74098.806.58262,950.404.733.616.755.0982.5382.976.384.951.424.150.73150.007.172.3349.0241.424.01--
Data as of Apr 17 2024. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

55.42%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20238.73m9.46%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20238.56m9.27%
BlackRock Fund Advisorsas of 31 Dec 20237.55m8.18%
Wellington Management Co. LLPas of 31 Dec 20237.16m7.76%
Fidelity Management & Research Co. LLCas of 31 Dec 20234.31m4.67%
Dimensional Fund Advisors LPas of 31 Dec 20233.32m3.60%
Invesco Advisers, Inc.as of 31 Dec 20233.07m3.33%
William Blair Investment Management LLCas of 31 Dec 20232.99m3.24%
Viking Global Investors LPas of 31 Dec 20232.80m3.03%
SSgA Funds Management, Inc.as of 31 Dec 20232.65m2.87%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.